Oneview Healthcare (ASX:ONE) Growth Rank: 7 (As of Aug. 04, 2026) — 250% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ONE Oneview Healthcare PLC ASX:ONE
37 GF Score
Price A$0.17
GF Value A$0.34
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Oneview Healthcare Growth Rank?

Oneview Healthcare ASX:ONE 37 Growth Rank is 7 as of Aug. 04, 2026, which is 250% above its 10-year median of 2.00. GuruFocus rates ASX:ONE with a GF Score™ of 37/100 and a GF Value™ of A$0.34 (Possible Value Trap). The stock has 5 warning signs investors should review.

Oneview Healthcare has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Oneview Healthcare Growth Rank Related Terms

ASX:ONE vs VEEV, BTSG, HQY: Growth Rank Comparison

For the Health Information Services subindustry, Oneview Healthcare's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oneview Healthcare Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's Growth Rank distribution charts can be found below:

* The bar in red indicates where Oneview Healthcare's Growth Rank falls into.


ASX:ONE
37GF Score
Oneview Healthcare PLC ASX:ONE
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
Oneview Healthcare (ASX:ONE) has a Growth Rank of 7 as of Aug. 04, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Oneview Healthcare and its competitors. This is 250% above median its historical median of 2.00. Over the past decade, Oneview Healthcare's Growth Rank has ranged from 1.00 to 7.00.
Is Oneview Healthcare's Growth Rank too high?
Oneview Healthcare's current Growth Rank of 7 is 250% above median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.00. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's Growth Rank compare to VEEV and BTSG?
Oneview Healthcare's Growth Rank of 7 can be compared against companies in the Healthcare Providers & Services industry. Historically, Oneview Healthcare's own Growth Rank has ranged from 1.00 to 7.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Oneview Healthcare and its competitors. Oneview Healthcare's current Growth Rank is 7, which is 250% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.34, compared to a current price of A$0.17 — trading 50% below its estimated fair value. The current Growth Rank is 7, which is 250% above median its 10-year median of 2.00. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current Growth Rank is 7 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?

Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued. The current stock price of A$0.17 is trading 50% below its estimated GF Value™ of A$0.34. GuruFocus considers Oneview Healthcare to be Possible Value Trap.

Key valuation signals for ASX:ONE:

  • Growth Rank: 7 (250% above median its 10-year median of 2.00)
  • GF Value™: A$0.34 vs. price of A$0.17 (50% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oneview Healthcare Business Description

Address Temple Road, 2nd Floor, Avoca Court, Blackrock Co, Dublin, IRL, A94 R7W3
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score

Get the complete analysis for ASX:ONE

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.17
Price
A$0.34
GF Value